CSIMarket
 


Nuvation Bio Inc   (NUVB)
Other Ticker:  
 

Nuvation Bio Inc 's Tangible Leverage Ratio

NUVB's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




NUVB Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -13.18 % -12.15 % -10.27 % 14819.92 % -
Y / Y Total Liabilities Change -34.73 % 5.26 % 9.83 % -78.45 % -
Tangible Leverage Ratio MRQ 0.03 0.04 0.04 0.04 0.04
Overall Ranking # # # # #
Seq. Tangible Equity Change -3.63 % -4.21 % -3.01 % -3.04 % -2.48 %
Seq. Total Liabilities Change -30.4 % -5.61 % -6.34 % 6.08 % 12.23 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to repayements of liabilities of -30.4% Nuvation Bio Inc improved Tangible Leverage Ratio in third quarter 2022 to 0.03, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is NUVB Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Nuvation Bio Inc 's Tangible Equity $ 668 Millions Visit NUVB's Balance sheet
Nuvation Bio Inc 's Total Liabilities $ 19 Millions Visit NUVB's Balance sheet
Source of NUVB's Sales Visit NUVB's Sales by Geography


Cumulative Nuvation Bio Inc 's Tangible Leverage Ratio

NUVB's Tangible Leverage Ratio for the trailling 12 Months

NUVB Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -13.18 % -12.15 % -10.27 % 14819.92 % -
Y / Y Total Liabilities TTM Growth -34.73 % 5.26 % 9.83 % -78.45 % -
Tangible Leverage Ratio TTM 0.04 0.04 0.04 0.04 0.09
Total Ranking TTM # 42 # 71 # 71 # 68 # 215
Seq. Tangible Equity TTM Growth -3.63 % -4.21 % -3.01 % -3.04 % -2.48 %
Seq. Total Liabilities TTM Growth -30.4 % -5.61 % -6.34 % 6.08 % 12.23 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to repayements of liabilities of -30.4% Nuvation Bio Inc has not changed Tangible Leverage Ratio in the III. Quarter to 0.04, a new company low.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 10 other companies have achieved lower Tangible Leverage Ratio than Nuvation Bio Inc . While total ranking remained unchanged compare to previous quarter at no. 42.

Explain Tangible Leverage Ratio?
What is NUVB Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 13
Within the Market # 42


TTM Tangible Leverage Ratio Statistics
High Average Low
0.21 0.07 0.04
(Jun 30 2021)   (Dec 31 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Kezar Life Sciences Inc   0.08 $ 21.582  Millions$ 283.188  Millions
Anebulo Pharmaceuticals Inc  0.07 $ 1.396  Millions$ 19.117  Millions
Ainos Inc   0.07 $ 2.656  Millions$ 36.426  Millions
Chimerix inc   0.07 $ 19.928  Millions$ 273.952  Millions
Xenetic Biosciences Inc   0.07 $ 1.051  Millions$ 14.522  Millions
Anaptysbio inc  0.07 $ 19.459  Millions$ 277.619  Millions
Pasithea Therapeutics Corp   0.07 $ 2.819  Millions$ 42.922  Millions
Olema Pharmaceuticals inc   0.07 $ 14.298  Millions$ 217.699  Millions
Syndax Pharmaceuticals Inc   0.06 $ 21.585  Millions$ 338.102  Millions
Oramed Pharmaceuticals Inc   0.06 $ 9.636  Millions$ 153.147  Millions
Annovis Bio inc   0.06 $ 1.846  Millions$ 29.961  Millions
Astria Therapeutics inc   0.06 $ 6.945  Millions$ 112.872  Millions
Tonix Pharmaceuticals Holding Corp   0.06 $ 13.722  Millions$ 228.924  Millions
Pardes Biosciences Inc   0.06 $ 12.028  Millions$ 202.013  Millions
Morphic Holding inc   0.06 $ 20.775  Millions$ 365.061  Millions
Io Biotech Inc   0.06 $ 8.668  Millions$ 153.489  Millions
Catalyst Biosciences Inc   0.06 $ 1.644  Millions$ 29.375  Millions
Nuvalent Inc   0.05 $ 12.975  Millions$ 236.583  Millions
Kura Oncology Inc   0.05 $ 22.983  Millions$ 419.621  Millions
Point Biopharma Global Inc   0.05 $ 16.608  Millions$ 309.080  Millions
Forte Biosciences Inc   0.05 $ 2.293  Millions$ 42.835  Millions
Theseus Pharmaceuticals inc   0.05 $ 11.699  Millions$ 218.594  Millions
Day One Biopharmaceuticals Inc   0.05 $ 18.785  Millions$ 363.076  Millions
Lantern Pharma Inc   0.05 $ 3.047  Millions$ 59.025  Millions
Cyteir Therapeutics Inc   0.05 $ 7.663  Millions$ 154.033  Millions
Terns Pharmaceuticals Inc   0.05 $ 8.892  Millions$ 183.694  Millions
Cohbar Inc   0.05 $ 0.896  Millions$ 18.728  Millions
Nextcure Inc   0.05 $ 8.368  Millions$ 181.541  Millions
Keros Therapeutics Inc   0.05 $ 11.070  Millions$ 241.025  Millions
Eliem Therapeutics Inc   0.05 $ 6.147  Millions$ 134.359  Millions

Date modified: 2022-11-06T03:44:33+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NTWK's Profile

Stock Price

NTWK's Financials

Business Description

Fundamentals

Charts & Quotes

NTWK's News

Suppliers

NTWK's Competitors

Customers & Markets

Economic Indicators

NTWK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071